ATE463243T1 - Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen - Google Patents

Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen

Info

Publication number
ATE463243T1
ATE463243T1 AT04734795T AT04734795T ATE463243T1 AT E463243 T1 ATE463243 T1 AT E463243T1 AT 04734795 T AT04734795 T AT 04734795T AT 04734795 T AT04734795 T AT 04734795T AT E463243 T1 ATE463243 T1 AT E463243T1
Authority
AT
Austria
Prior art keywords
ketorolac
salts
pharmaceutical
pharmaceutical composition
pharmaceutically acceptable
Prior art date
Application number
AT04734795T
Other languages
English (en)
Inventor
Guido Vandoni
Carlo Oliani
Adriano Coelho
Heny Zaniboni
Original Assignee
Nature S Plus Farmaceutica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36584875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE463243(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nature S Plus Farmaceutica Ltd filed Critical Nature S Plus Farmaceutica Ltd
Application granted granted Critical
Publication of ATE463243T1 publication Critical patent/ATE463243T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04734795T 2003-06-02 2004-05-26 Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen ATE463243T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0302736A BRPI0302736B8 (pt) 2003-06-02 2003-06-02 composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
PCT/BR2004/000077 WO2004105678A2 (en) 2003-06-02 2004-05-26 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE463243T1 true ATE463243T1 (de) 2010-04-15

Family

ID=36584875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04734795T ATE463243T1 (de) 2003-06-02 2004-05-26 Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen

Country Status (7)

Country Link
US (1) US7879901B2 (de)
EP (1) EP1633342B1 (de)
AT (1) ATE463243T1 (de)
BR (1) BRPI0302736B8 (de)
DE (1) DE602004026437D1 (de)
ES (1) ES2344984T3 (de)
WO (1) WO2004105678A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
WO2008150887A1 (en) * 2007-05-29 2008-12-11 Livescribe, Inc. Self-addressing paper
MX2013008993A (es) 2013-08-02 2014-03-24 Raam De Sahuayo S A De C V Lab Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide.
UA126916C2 (uk) * 2017-04-27 2023-02-22 Др. Редді'З Лабораторіз Лімітед Фармацевтична композиція кеторолаку
PE20260437A1 (es) * 2023-04-13 2026-02-19 Ache Laboratorios Farmaceuticos Sa Composicion farmaceutica oral, proceso para producir de granulos o una composicion farmaceutica oral, granulo farmaceutico oral, uso de la composicion farmaceutica y metodo para tratar afecciones inflamatorias, dolores y/o moderar el uso de opioides perioperatorios
KR20260087499A (ko) * 2024-12-04 2026-06-11 아테나 파르마쎄티크 에스에이에스 케토롤락 트로메타민 설하정의 제조 방법 및 이를 위한 정제 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
ATE137967T1 (de) 1990-03-16 1996-06-15 Procter & Gamble Verwendung von ketorolac zur behandlung von periodontitis
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
JPH08503465A (ja) 1992-11-09 1996-04-16 ファーメトリックス コーポレイション ケトロラックの経皮デリバリー
US5626838A (en) 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6090368A (en) 1998-03-03 2000-07-18 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
CA2419592A1 (en) * 2000-08-18 2002-02-28 Pharmacia Corporation Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
CA2474190A1 (en) * 2002-02-07 2003-08-14 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery

Also Published As

Publication number Publication date
EP1633342B1 (de) 2010-04-07
DE602004026437D1 (de) 2010-05-20
EP1633342A4 (de) 2008-03-05
ES2344984T3 (es) 2010-09-13
BRPI0302736B8 (pt) 2021-05-25
BR0302736A (pt) 2005-05-10
US7879901B2 (en) 2011-02-01
EP1633342A2 (de) 2006-03-15
BR0302736B1 (pt) 2014-07-29
WO2004105678A2 (en) 2004-12-09
WO2004105678A3 (en) 2005-04-21
US20060128782A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
EP1106605A4 (de) Antagonisten des andrenergen-alpha1b-rezeptors
NO20045072L (no) Tablett med hoyt medikamentinnhold
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
IL154988A0 (en) Pharmaceutical compositions containing a 5-ht3 receptor antagonist
NO20062098L (no) Faststofftilstandmontelukast
TW200621257A (en) Pyrimidine derivative fused with nonaromatic ring
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
PE20091322A1 (es) Composicion farmaceutica antimalarica
BRPI0413186A (pt) composição de fexofenadina e processo para preparação da mesma
EA200000487A1 (ru) Композиция пролонгированного высвобождения
RU2004135078A (ru) Травяная молекула как потенциальное противолейкозное лекарственное средство
DE602004026437D1 (de) Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen
RU2012109392A (ru) Фармацевтическая композиция для ослабления боли
DE60301351D1 (de) Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
UA92134C2 (ru) Соединение, обладающее анти-вгс действием, и фармацевтическая композиция, содержащая его
ES2083708T3 (es) Nuevas piperazinilalcoil-3 dihidro-2,3,4h-benzoxazina-1,3 onas-4 sustituidas, su preparacion y su aplicacion en terapeutica.
MD522G2 (ro) Noi derivaţi de piperidinii tioindol, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizare a lor ca analgezice
BR0207297A (pt) Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
EA200100869A1 (ru) Кристаллическая форма эплеренона
PL1778209T3 (pl) Sposoby i kompozycje do doustnego dostarczania FTS
WO2007120930A3 (en) Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties